Narrative review / 2011
A roundtable supported reinstating vitamin B-12 biomarkers in NHANES, preferring both serum vitamin B-12 and plasma methylmalonic acid.
In July 2010, a roundtable convened to evaluate vitamin B-12 status biomarkers for NHANES, which had discontinued measuring them after 2006. The panel reviewed serum vitamin B-12, methylmalonic acid (MMA), and total homocysteine, and discussed holotranscobalamin. Members supported reinstating vitamin B-12 measures, preferring the combination of serum vitamin B-12 and plasma MMA to ensure continuity with past surveys. They also highlighted uncertainties surrounding subclinical deficiency and emphasized the need for clinical trials assessing causal links to adverse health outcomes and defining appropriate biomarker cutoffs.
- Study type
- Roundtable summary / review
- Who was studied
- U.S. population represented in NHANES
- What was measured
- Measurement and selection of vitamin B-12 status biomarkers for NHANES
THE PAPER
Biomarkers of vitamin B-12 status in NHANES: a roundtable summary.
Yetley EA, Pfeiffer CM, Phinney KW, Bailey RL, Blackmore S, Bock JL, Brody LC, Carmel R, Curtin LR, Durazo-Arvizu RA, Eckfeldt JH, Green R, Gregory JF, Hoofnagle AN, Jacobsen DW, Jacques PF, Lacher DA, Molloy AM, Massaro J, Mills JL, Nexo E, Rader JI, Selhub J, Sempos C, Shane B, Stabler S, Stover P, Tamura T, Tedstone A, Thorpe SJ, Coates PM, Johnson CL, Picciano MF. Am J Clin Nutr, 2011.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.